Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,767,226
-
Share change
-
+3,045,018
-
Total reported value
-
$2,386,992,650
-
Put/Call ratio
-
262%
-
Price per share
-
$80.19
-
Number of holders
-
128
-
Value change
-
+$259,923,476
-
Number of buys
-
94
-
Number of sells
-
28
Institutional Holders of LOXO ONCOLOGY INC - COM (LOXO) as of Q2 2017
As of 30 Jun 2017 LOXO ONCOLOGY INC - COM (LOXO) had 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,767,226 shares of stock of the company.
Largest 10 holders included FMR LLC, Aisling Capital LLC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, VICTORY CAPITAL MANAGEMENT INC, and LORD, ABBETT & CO. LLC.
This table shows 128 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.